My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 404

    1.

    A randomized trial of sibutramine in the management of obese type 2 diabetic patients treated with metformin.

    McNulty SJ, Ur E, Williams G; Multicenter Sibutramine Study Group.

    Diabetes Care. 2003 Jan;26(1):125-31.PMID: 12502668 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    [Pharmacological therapy of obesity]

    Pagotto U, Vanuzzo D, Vicennati V, Pasquali R.

    G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):83S-93S. Italian. PMID: 18773755 [PubMed - indexed for MEDLINE]Related articles

    3.

    Weight loss with sibutramine improves glycaemic control and other metabolic parameters in obese patients with type 2 diabetes mellitus.

    Fujioka K, Seaton TB, Rowe E, Jelinek CA, Raskin P, Lebovitz HE, Weinstein SP; Sibutramine/Diabetes Clinical Study Group.

    Diabetes Obes Metab. 2000 Jun;2(3):175-87.PMID: 11220553 [PubMed - indexed for MEDLINE]Related articles

    4.

    Sibutramine is effective for weight loss and diabetic control in obesity with type 2 diabetes: a randomised, double-blind, placebo-controlled study.

    Finer N, Bloom SR, Frost GS, Banks LM, Griffiths J.

    Diabetes Obes Metab. 2000 Apr;2(2):105-12.PMID: 11220522 [PubMed - indexed for MEDLINE]Related articles

    5.

    Effects of sibutramine in obese female subjects with type 2 diabetes and poor blood glucose control.

    Gokcel A, Karakose H, Ertorer EM, Tanaci N, Tutuncu NB, Guvener N.

    Diabetes Care. 2001 Nov;24(11):1957-60.PMID: 11679464 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Pioglitazone metabolic effect in metformin-intolerant obese patients treated with sibutramine.

    Derosa G, Mereu R, Salvadeo SA, D'Angelo A, Ciccarelli L, Piccinni MN, Ferrari I, Gravina A, Maffioli P, Cicero AF.

    Intern Med. 2009;48(5):265-71. Epub 2009 Mar 2.PMID: 19252346 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Use of sibutramine in overweight adult hispanic patients with type 2 diabetes mellitus: a 12-month, randomized, double-blind, placebo-controlled clinical trial.

    Sánchez-Reyes L, Fanghänel G, Yamamoto J, Martínez-Rivas L, Campos-Franco E, Berber A.

    Clin Ther. 2004 Sep;26(9):1427-35.PMID: 15531005 [PubMed - indexed for MEDLINE]Related articles

    8.

    Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone.

    Derosa G, D'Angelo A, Salvadeo SA, Ferrari I, Gravina A, Fogari E, Maffioli P, Cicero AF.

    Metabolism. 2008 Nov;57(11):1552-7.PMID: 18940393 [PubMed - indexed for MEDLINE]Related articles

    9.

    Effect of orlistat in overweight and obese patients with type 2 diabetes treated with metformin.

    Miles JM, Leiter L, Hollander P, Wadden T, Anderson JW, Doyle M, Foreyt J, Aronne L, Klein S.

    Diabetes Care. 2002 Jul;25(7):1123-8. Erratum in: Diabetes Care. 2002 Sep;25(9):1671.. PMID: 12087008 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control.

    Robinson AC, Burke J, Robinson S, Johnston DG, Elkeles RS.

    Diabetes Care. 1998 May;21(5):701-5.PMID: 9589227 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Efficacy and safety of sibutramine in obese white and African American patients with hypertension: a 1-year, double-blind, placebo-controlled, multicenter trial.

    McMahon FG, Fujioka K, Singh BN, Mendel CM, Rowe E, Rolston K, Johnson F, Mooradian AD.

    Arch Intern Med. 2000 Jul 24;160(14):2185-91.PMID: 10904462 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Clinical efficacy of orlistat therapy in overweight and obese patients with insulin-treated type 2 diabetes: A 1-year randomized controlled trial.

    Kelley DE, Bray GA, Pi-Sunyer FX, Klein S, Hill J, Miles J, Hollander P.

    Diabetes Care. 2002 Jun;25(6):1033-41. Erratum in: Diabetes Care. 2003 Mar;26(3):971.. PMID: 12032111 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Dexfenfluramine in obese Chinese NIDDM patients. A placebo-controlled investigation of the effects on body weight, glycemic control, and cardiovascular risk factors.

    Chow CC, Ko GT, Tsang LW, Yeung VT, Chan JC, Cockram CS.

    Diabetes Care. 1997 Jul;20(7):1122-7.PMID: 9203448 [PubMed - indexed for MEDLINE]Related articles

    14.

    Role of sibutramine in the treatment of obese Type 2 diabetic patients receiving sulphonylurea therapy.

    Serrano-Rios M, Melchionda N, Moreno-Carretero E; Spanish Investigators.

    Diabet Med. 2002 Feb;19(2):119-24.PMID: 11874427 [PubMed - indexed for MEDLINE]Related articles

    15.

    Weight reduction by sibutramine in obese subjects in primary care medicine: the SAT Study.

    Hauner H, Meier M, Wendland G, Kurscheid T, Lauterbach K, Study Group SA; SAT Study.

    Exp Clin Endocrinol Diabetes. 2004 Apr;112(4):201-7.PMID: 15127325 [PubMed - indexed for MEDLINE]Related articles

    16.

    Addition of benfluorex to biguanide improves glycemic control in obese non-insulin-dependent diabetes: a double-blind study versus placebo.

    Roger P, Auclair J, Drain P.

    J Diabetes Complications. 1999 Mar-Apr;13(2):62-7.PMID: 10432168 [PubMed - indexed for MEDLINE]Related articles

    17.

    Comparison of metabolic effects of orlistat and sibutramine treatment in Type 2 diabetic obese patients.

    Derosa G, Cicero AF, Murdolo G, Ciccarelli L, Fogari R.

    Diabetes Nutr Metab. 2004 Aug;17(4):222-9.PMID: 15575343 [PubMed - indexed for MEDLINE]Related articles

    18.

    Long-term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: a 12-month, double-blind, randomized clinical trial.

    Derosa G, Cicero AF, Gaddi AV, Ciccarelli L, Piccinni MN, Salvadeo S, Pricolo F, Fogari E, Ghelfi M, Ferrari I, Fogari R.

    Clin Ther. 2005 Sep;27(9):1383-91.PMID: 16291411 [PubMed - indexed for MEDLINE]Related articles

    19.

    Sibutramine improves insulin sensitivity without alteration of serum adiponectin in obese subjects with Type 2 diabetes.

    Hung YJ, Chen YC, Pei D, Kuo SW, Hsieh CH, Wu LY, He CT, Lee CH, Fan SC, Sheu WH.

    Diabet Med. 2005 Aug;22(8):1024-30.PMID: 16026368 [PubMed - indexed for MEDLINE]Related articles

    20.

    Latin-American trial of orlistat for weight loss and improvement in glycaemic profile in obese diabetic patients.

    Halpern A, Mancini MC, Suplicy H, Zanella MT, Repetto G, Gross J, Jadzinsky M, Barranco J, Aschner P, Ramirez L, Matos AG.

    Diabetes Obes Metab. 2003 May;5(3):180-8.PMID: 12681025 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity